A Life-Course Assessment of Treatment Patterns and Healthcare Costs of Lennox-Gastaut Syndrome (LGS) (P1.085)

Conclusions: LGS has a lifelong impact on patients, amassing greater total healthcare and medical costs from childhood through adulthood than all epilepsy patients. LGS-specific AEDs are underutilized in LGS patients. Increased clinical attention to LGS beyond pediatric years is warranted. Funding: Lundbeck, LLCDisclosure: Dr. Montouris has received personal compensation for activities with Lundbeck Research USA, Inc. Acorda Therapeutics, Eisai Inc. for serving on the advisory board member. Dr. Pina-Garza has received personal compensation for activities with Eisai Inc. as a consultant. Dr. Vekeman has nothing to disclose. Dr. Cheng has received personal compensation for activities with the Analysis Group as an employee. Dr. Tuttle has received personal compensation for activities with Analysis Group as an employee. Dr. Giguere-Duval has received personal compensation for activities with Group d'analyse, Ltee as an employee. Dr. Duh has received research support from Cyberonics, Inc and GlaxoSmithKline. Dr. Shen has received personal compensation for activities with Lundbeck Inc. as an employee. Dr. Isojarvi has received personal compensation fro activities with Lundbeck LLC.

Source: Neurology - April 3, 2016 Category: Neurology Authors: Montouris, G., Piňa-Garza, J. E., Vekeman, F., Cheng, W., Tuttle, E., Giguere-Duval, P., Duh, M. S., Shen, V., Isojarvi, J. Tags: Epilepsy/Clinical Neurophysiology: Geriatric Epilepsy, Epidemiology, and Health Services Source Type: research